Quantcast

Latest Imatinib Stories

2013-10-08 09:44:05

Two gene alterations pair up to promote the growth of leukemia cells and their escape from anti-cancer drugs, according to a study in The Journal of Experimental Medicine. Chronic myeloid leukemia (CML) is an aggressive cancer of the blood that is often treated with a drug called Imatinib (a.k.a. Gleevec). Although Gleevec is highly effective, some cancer cells can develop resistance to the drug. The mechanism that drives this resistance is not completely understood, but there is evidence...

2013-09-18 23:04:35

Reportbuyer.com just published a new market research report: PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022 London (PRWEB) September 18, 2013 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL...

Leukemia Drug Prices Too Costly
2013-04-27 06:38:21

redOrbit Staff & Wire Reports - Your Universe Online More than 100 influential oncologists from over 15 different countries have joined forces to demand pharmaceutical companies reduce the prices of potentially life-saving cancer medication, some of which can cost patients in excess of $100,000 per year. In a commentary published Thursday by Blood, the journal of the American Society of Hematology, 120 doctors and researchers specializing in the treatment of chronic myeloid leukemia...

2013-04-08 12:36:41

A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10. The findings (Abstract LB-295) will be released at a press conference on Saturday, April 6, 3:00 p.m. ET, and later at an oral presentation on Tuesday, April 9, 3:35 —...

2013-04-05 00:20:07

National Foundation for Cancer Research (NFCR) honours Professor Alex Matter with esteemed award for groundbreaking cancer pill that gives leukaemia patients a new lease of life.Singapore, Apr 5, 2013 - (ACN Newswire) - Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related